SoftSeal-STF Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC
  • (In Progress)

  • Latest Deal Amount
  • $1.05M

SoftSeal-STF General Information

Description

Operator of a medical device company intended to develop next-generation proprietary hemostatic products. The company's hemostatic pad is biodegradable and biocompatible promotes the formation of a strong, stable clot, reduces the duration and amount of compression required, promotes early ambulation, and adheres to bleeding tissues, enabling doctors to help in controlling bleeding after an injury.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Corporate Office
  • 12805 Highway 55
  • Suite 202
  • Plymouth, MN 55441
  • United States
+1 (763) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SoftSeal-STF Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 13-Dec-2023 $1.05M 00.000 In Progress Generating Revenue
7. Seed Round 15-Dec-2022 Cancelled Generating Revenue
6. Seed Round 06-May-2022 00000 00.000 Completed Generating Revenue
5. Angel (individual) 29-May-2015 0000 00.000 Completed Generating Revenue
4. Seed Round 01-Jul-2014 00.000 00.000 Completed Generating Revenue
3. Angel (individual) 20-Mar-2013 00000 00000 Completed Generating Revenue
2. Angel (individual) 21-Jan-2009 $55K Completed Generating Revenue
1. Angel (individual) 01-Jul-2008 $55K $55K Completed Generating Revenue
To view SoftSeal-STF’s complete valuation and funding history, request access »

SoftSeal-STF Patents

SoftSeal-STF Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11027041-B2 Stable and robust blended hemostatic composition Active 30-Jun-2019 00000000000 0
US-20200405907-A1 Stable and robust blended hemostatic composition Active 30-Jun-2019 00000000000
US-20160168276-A1 Process for the removal of endotoxins to produce medical quality chitosan and other polysaccharides Active 16-Dec-2014 0000000000 0
US-9598504-B2 Process for the removal of endotoxins to produce medical quality chitosan and other polysaccharides Active 16-Dec-2014 0000000000 00
US-10137219-B2 Coherent blood coagulation structure of water-insoluble chitosan and water-dispersible starch coating Active 04-Aug-2014 A61L15/28 00
To view SoftSeal-STF’s complete patent history, request access »

SoftSeal-STF Executive Team (6)

Name Title Board Seat Contact Info
Steven Muellerleile Chief Executive Officer & President
Albert Emola Chief Executive Officer, Board Member & President
James Drake Ph.D Co-Founder, Chief Technology Officer & & Chairman
Donald Sturtevant Co-Founder & Board Member
Douglas Eayrs Co-Founder, Chief Financial Officer & Board Member
You’re viewing 5 of 6 executive team members. Get the full list »

SoftSeal-STF Board Members (8)

Name Representing Role Since
Albert Emola SoftSeal-STF Chief Executive Officer, Board Member & President 000 0000
Donald Sturtevant SoftSeal-STF Co-Founder & Board Member 000 0000
Douglas Eayrs Self Co-Founder, Chief Financial Officer & Board Member 000 0000
Frederick Albright SoftSeal-STF Board Member 000 0000
James Drake Ph.D SoftSeal-STF Co-Founder, Chief Technology Officer & & Chairman 000 0000
You’re viewing 5 of 8 board members. Get the full list »

SoftSeal-STF Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »